APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Milk Oligosaccharides (HMO)

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Selected research

Industry Research

Human Milk Oligosaccharides (HMO) Industry Research Report 2026

8 January 2026118 pages

Choose your research edition.

Industry ResearchHuman Milk Oligosaccharides (HMO) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global core Human Milk Oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%.North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 34% and 14%.

Report Scope

Read the full market overview

This report quantifies the global Human Milk Oligosaccharides (HMO) market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Milk Oligosaccharides (HMO) Market by Company

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Dextra Laboratories

Human Milk Oligosaccharides (HMO) Segment by Type

2'-FL & 3-FL

Sialyllactose

LNT & LNnT

Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Functional Food & Beverages

Food/Medical Supplements

Others

Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Milk Oligosaccharides (HMO) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Milk Oligosaccharides (HMO) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Milk Oligosaccharides (HMO) Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Milk Oligosaccharides (HMO) Revenue of Manufacturers (2021-2026) Table 9. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) of Manufacturers (2021-2026) Table 11. Global Human Milk Oligosaccharides (HMO) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application Table 14. Global Human Milk Oligosaccharides (HMO) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Company Information Table 19. Abbott Business Overview Table 20. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 21. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio Table 22. Abbott Recent Developments Table 23. Inbiose Company Information Table 24. Inbiose Business Overview Table 25. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 26. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio Table 27. Inbiose Recent Developments Table 28. Glycom Company Information Table 29. Glycom Business Overview Table 30. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 31. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio Table 32. Glycom Recent Developments Table 33. Chr. Hansen (Jennewein) Company Information Table 34. Chr. Hansen (Jennewein) Business Overview Table 35. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 36. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio Table 37. Chr. Hansen (Jennewein) Recent Developments Table 38. Elicityl SA Company Information Table 39. Elicityl SA Business Overview Table 40. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 41. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio Table 42. Elicityl SA Recent Developments Table 43. ZuChem Company Information Table 44. ZuChem Business Overview Table 45. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 46. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio Table 47. ZuChem Recent Developments Table 48. Dextra Laboratories Company Information Table 49. Dextra Laboratories Business Overview Table 50. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 51. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio Table 52. Dextra Laboratories Recent Developments Table 53. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 54. Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (Tons) Table 55. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026) Table 56. Global Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032) & (Tons) Table 57. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2027-2032) Table 58. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2026) Table 60. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2027-2032) Table 62. North America Human Milk Oligosaccharides (HMO) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. North America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 64. North America Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 65. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & (US$ Million) Table 66. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2027-2032) & (US$ Million) Table 67. Europe Human Milk Oligosaccharides (HMO) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 69. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 70. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & (US$ Million) Table 71. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2027-2032) & (US$ Million) Table 72. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 74. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 75. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & (US$ Million) Table 76. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2027-2032) & (US$ Million) Table 77. South America Human Milk Oligosaccharides (HMO) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. South America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 79. South America Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 80. South America Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & (US$ Million) Table 81. South America Human Milk Oligosaccharides (HMO) Revenue by Country (2027-2032) & (US$ Million) Table 82. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 84. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 85. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & (US$ Million) Table 86. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2027-2032) & (US$ Million) Table 87. Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 88. Global Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (Tons) Table 89. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026) Table 90. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2027-2032) Table 91. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 92. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 93. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026) Table 94. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2027-2032) Table 95. Global Human Milk Oligosaccharides (HMO) Price by Type (2021-2026) & (USD/Ton) Table 96. Global Human Milk Oligosaccharides (HMO) Price by Type (2027-2032) & (USD/Ton) Table 97. Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 98. Global Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (Tons) Table 99. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026) Table 100. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2027-2032) Table 101. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 102. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 103. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2026) Table 104. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2027-2032) Table 105. Global Human Milk Oligosaccharides (HMO) Price by Application (2021-2026) & (USD/Ton) Table 106. Global Human Milk Oligosaccharides (HMO) Price by Application (2027-2032) & (USD/Ton) Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Human Milk Oligosaccharides (HMO) Distributors List Table 110. Human Milk Oligosaccharides (HMO) Customers List Table 111. Human Milk Oligosaccharides (HMO) Industry Trends Table 112. Human Milk Oligosaccharides (HMO) Industry Drivers Table 113. Human Milk Oligosaccharides (HMO) Industry Restraints Table 114. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Milk Oligosaccharides (HMO) Product Image Figure 5. Global Human Milk Oligosaccharides (HMO) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Milk Oligosaccharides (HMO) Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (Tons) Figure 8. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) & (2021-2032) Figure 9. 2'-FL & 3-FL Product Image Figure 10. Sialyllactose Product Image Figure 11. LNT & LNnT Product Image Figure 12. Infant Formula Product Image Figure 13. Functional Food & Beverages Product Image Figure 14. Food/Medical Supplements Product Image Figure 15. Others Product Image Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Human Milk Oligosaccharides (HMO) Sales by Region in 2025 Figure 22. Global Human Milk Oligosaccharides (HMO) Revenue by Region in 2025 Figure 23. North America Human Milk Oligosaccharides (HMO) Market Size by Country in 2025 Figure 24. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 25. North America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2032) Figure 26. United States Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Human Milk Oligosaccharides (HMO) Market Size by Country in 2025 Figure 30. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 31. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2032) Figure 32. Germany Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country in 2025 Figure 43. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2032) Figure 45. China Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Human Milk Oligosaccharides (HMO) Market Size by Country in 2025 Figure 54. South America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 55. South America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2032) Figure 56. Brazil Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country in 2025 Figure 60. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2032) Figure 62. Egypt Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032) Figure 68. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032) Figure 69. Global Human Milk Oligosaccharides (HMO) Price (USD/Ton) by Type (2021-2032) Figure 70. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032) Figure 71. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032) Figure 72. Global Human Milk Oligosaccharides (HMO) Price (USD/Ton) by Application (2021-2032) Figure 73. Human Milk Oligosaccharides (HMO) Value Chain Figure 74. Human Milk Oligosaccharides (HMO) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges

Scope & coverage.

Types
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT
Applications
  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements
  • Others
Companies covered
  • Abbott
  • Inbiose
  • Glycom
  • Chr. Hansen (Jennewein)
  • Elicityl SA
  • ZuChem
  • Dextra Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Milk Oligosaccharides (HMO) Market Size (2021-2032)
  4. 2.2.2 Global Human Milk Oligosaccharides (HMO) Sales (2021-2032)
  5. 2.2.3 Global Human Milk Oligosaccharides (HMO) Market Average Price (2021-2032)
  6. 2.3 Human Milk Oligosaccharides (HMO) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 2'-FL & 3-FL
  9. 2.3.3 Sialyllactose
  10. 2.3.4 LNT & LNnT
  11. 2.4 Human Milk Oligosaccharides (HMO) by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Infant Formula
  14. 2.4.3 Functional Food & Beverages
  15. 2.4.4 Food/Medical Supplements
  16. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Milk Oligosaccharides (HMO) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Milk Oligosaccharides (HMO) Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Human Milk Oligosaccharides (HMO) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Milk Oligosaccharides (HMO) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application
  8. 3.8 Global Manufacturers of Human Milk Oligosaccharides (HMO), Established Date
  9. 3.9 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Company Information
  3. 4.1.2 Abbott Business Overview
  4. 4.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 Inbiose
  8. 4.2.1 Inbiose Company Information
  9. 4.2.2 Inbiose Business Overview
  10. 4.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 4.2.5 Inbiose Recent Developments
  13. 4.3 Glycom
  14. 4.3.1 Glycom Company Information
  15. 4.3.2 Glycom Business Overview
  16. 4.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 4.3.5 Glycom Recent Developments
  19. 4.4 Chr. Hansen (Jennewein)
  20. 4.4.1 Chr. Hansen (Jennewein) Company Information
  21. 4.4.2 Chr. Hansen (Jennewein) Business Overview
  22. 4.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 4.4.5 Chr. Hansen (Jennewein) Recent Developments
  25. 4.5 Elicityl SA
  26. 4.5.1 Elicityl SA Company Information
  27. 4.5.2 Elicityl SA Business Overview
  28. 4.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 4.5.5 Elicityl SA Recent Developments
  31. 4.6 ZuChem
  32. 4.6.1 ZuChem Company Information
  33. 4.6.2 ZuChem Business Overview
  34. 4.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 4.6.5 ZuChem Recent Developments
  37. 4.7 Dextra Laboratories
  38. 4.7.1 Dextra Laboratories Company Information
  39. 4.7.2 Dextra Laboratories Business Overview
  40. 4.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
  42. 4.7.5 Dextra Laboratories Recent Developments
5 Global Human Milk Oligosaccharides (HMO) Market Scenario by Region
  1. 5.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021-2032
  3. 5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021-2026
  4. 5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2027-2032
  5. 5.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2027-2032
  8. 5.4 North America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
  9. 5.4.1 North America Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  11. 5.4.3 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
  16. 5.5.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  18. 5.5.3 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
  41. 5.7.1 South America Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  43. 5.7.3 South America Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  2. 6.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Milk Oligosaccharides (HMO) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  2. 7.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Milk Oligosaccharides (HMO) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 8.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Milk Oligosaccharides (HMO) Production Mode & Process
  5. 8.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Milk Oligosaccharides (HMO) Distributors
  8. 8.2.3 Human Milk Oligosaccharides (HMO) Customers
9 Global Human Milk Oligosaccharides (HMO) Analyzing Market Dynamics
  1. 9.1 Human Milk Oligosaccharides (HMO) Industry Trends
  2. 9.2 Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 9.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 9.4 Human Milk Oligosaccharides (HMO) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst